Raymond James Upgrade Boosts Oscar Health Stock After Q4 Earnings
Oscar Health Inc (NYSE:OSCR) shares are climbing on Thursday. The company posted fourth‑quarter results that missed expectations on both revenue and earnings, but had a stronger‑than‑expected 2026 outlook.
- Oscar Health stock is gaining positive traction. Why are OSCR shares climbing?
What The Numbers Showed
Oscar reported a quarterly loss of $1.24 per share, wider than the 89 cent loss analysts were expecting and a notable step back from the 62 cent loss a year ago. Revenue also came in light at $2.81 billion, below the $3.12 billion consensus, though it still marked 17% year‑over‑year growth.
Guidance May Be Helping The Stock
The company issued 2026 revenue guidance of $18.7 billion to $19.0 billion, dramatically above the Street's $12.565 billion estimate. Oscar also expects a medical loss ratio of 82.4% to 83.4% and operating earnings between $250 million and $450 million for the year.
Raymond James Upgrade Adds Momentum
Helping fuel the rally, Raymond James upgraded Oscar Health shares from Market Perform to Outperform, setting an $18 price target versus the stock's current level around $13.60. The firm called Oscar "the best house in a tough neighborhood," pointing to an attractive valuation as ACA exchange margins begin to recover.
Raymond James expects Oscar to generate roughly 2% EBIT margin in 2026, expanding to around 4% in 2027 as the medical loss ratio improves through repricing and G&A efficiencies. The firm added that much of the uncertainty around ACA subsidies and integrity rules is already reflected in the stock, creating a steadier backdrop for modest margin improvement. Oscar's long‑term EPS target remains $2.25.
OSCR Price Action: Oscar Health shares were up 0.96% at $13.73 at the time of publication on Thursday, according to Benzinga Pro.
Image: Tada Images/Shutterstock.com
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Musk on chip production: China's large-scale manufacturing capacity often exceeds the sum of all other regions worldwide
After ChangXin Memory Technologies announced a key breakthrough in DDR5 server memory, the Philadelphia Semiconductor Index in the US stock market fell 2.7% overnight, with shares such as Micron and SK Hynix ADR dropping collectively. Musk commented on this trend, saying that when China figures out the manufacturing method of a product, its ability to scale production often exceeds that of the rest of the world combined, and stated that "China seems to be rapidly conquering" general standard specifications such as LP5 and LP6.
IREN reports $702.6 million net loss despite $4 billion in AI cloud contracts
The current AI frenzy: featuring both "Tech and Internet" and "Real Estate" bubble characteristics, reminiscent of the 2008 global capital cycle
This wave of the AI boom exhibits dual characteristics: On a micro level, the heavy-asset nature of AI data centers is driving the industry toward "real estate-like" debt financing models, such as corporate bonds, private credit, and computing power ABS. On a macro level, nearly $2 trillion in overseas excess savings is flowing into core AI assets in the U.S. stock market through private institutions, reconstructing a transnational capital cycle reminiscent of the period before the 2008 subprime mortgage crisis. With nearly $3 trillion in off-balance sheet debt and rising interest rates, the industry is facing an impending major liquidity test.
AI Trading Faces a "Vulnerable Moment"! Japan and South Korea Stock Markets Experience "Black Tuesday" as SK Hynix, Samsung, and SoftBank Plunge Together
On Tuesday, Asian tech stocks faced a new round of systemic sell-off as the overnight weakness in the US semiconductor sector spread to the Asia-Pacific market. Concerns intensified over increasingly fierce competition due to the technological breakthrough by Chinese memory chip manufacturer ChangXin Memory Technologies, as well as worries about the returns on AI capital expenditure and the overall financing environment.
Crypto prices
More
